These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2774764)

  • 1. Dopamine receptors in the mouse vas deferens.
    Smith CF; Rowland PB
    Arch Int Pharmacodyn Ther; 1989; 299():144-54. PubMed ID: 2774764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of dopamine and dopaminergic agonists on the contractions of field stimulated rat vas deferens.
    György L; Orr Z; Folly G; Dóda M
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):55-64. PubMed ID: 6268006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0923), a selective D2 dopamine receptor agonist demonstrates the presence of D2 dopamine receptors in the mouse vas deferens but not in the rat vas deferens.
    Martin PL; Kelly M; Cusack NJ
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1342-8. PubMed ID: 7903387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 2-agonist activity of the dopamine DA2-agonist LY171555.
    Cohen ML; Shaar CJ; Colbert WE
    J Cardiovasc Pharmacol; 1984; 6(6):1245-8. PubMed ID: 6084786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of the partial dopamine receptor agonist, terguride, on the field-stimulated vas deferens in the mouse].
    Carratù MR; De Serio A; Lagioia R; Conte-Camerino D; Ferrari E; Mitolo-Chieppa D
    Boll Soc Ital Biol Sper; 1990 Jan; 66(1):35-42. PubMed ID: 1969741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonist activity of 8-OH-DPAT.
    Smith CF; Cutts S
    Arch Int Pharmacodyn Ther; 1990; 306():106-13. PubMed ID: 1981664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopaminoceptor agonists and antagonists on the rat vas deferens "in vitro".
    Tayo FM
    West Afr J Pharmacol Drug Res; 1979; 5(1):45-53. PubMed ID: 555128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation.
    Sharma A; Kulkarni SK
    Indian J Exp Biol; 1994 Mar; 32(3):176-9. PubMed ID: 8070837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine modulates peripheral purinergic neurotransmission through multiple presynaptic receptors: tissue-dependent effects.
    El-Mas MM; Elmallah AI; Omar AG; Sharabi F
    Pharmacol Res; 1999 Jan; 39(1):11-9. PubMed ID: 10051373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of dopamine-induced contractions of the rat vas deferens by low concentrations of its antagonists.
    Tayo FM
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):190-6. PubMed ID: 526075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prejunctional inhibitory dopamine receptors in the rat isolated vas deferens.
    Tayo FM
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):28-37. PubMed ID: 6121537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to finding specific dopamine D4 receptor agonists.
    Morishita H; Shibata K; Sakata N; Kita S; Katsuragi T
    Eur J Pharmacol; 2005 Jun; 516(2):145-50. PubMed ID: 15922324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole.
    Virtanen R; Savola JM; Saano V
    Arch Int Pharmacodyn Ther; 1989; 297():190-204. PubMed ID: 2567152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological responses by different portions of guinea pig vas deferens circular muscle preparation.
    Minker E; Bartha C
    Acta Physiol Acad Sci Hung; 1981; 58(1):65-77. PubMed ID: 6123218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the existence of prejunctional receptor sites for dopamine in the mouse vas deferens.
    Carratù MR; Conte-Camerino D; De Serio A; Ferrari E; Mitolo-Chieppa D
    J Auton Nerv Syst; 1989 Aug; 27(3):221-8. PubMed ID: 2794348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the inhibitory 5-HT receptor in the rat vas deferens.
    Smith CF; Bennett RT
    Arch Int Pharmacodyn Ther; 1990; 308():76-85. PubMed ID: 1983066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced alpha2A-autoreceptor reserve for clonidine induced by reserpine and cholinomimetic agents in the rat vas deferens.
    Pineda J; Ugedo L; García-Sevilla JA
    Br J Pharmacol; 1997 Nov; 122(5):833-40. PubMed ID: 9384498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular effects of selective dopamine receptor agonists and antagonists in the rat kidney.
    Schmidt M; Krieger JP; Giesen-Crouse EM; Imbs JL
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):195-205. PubMed ID: 2954515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.